New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Amneal Pharmaceuticals, Inc.
AMRX
Shape
US Flag

NYSE

4B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Mar 2025

4B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Mar 2025

7.98USD

Shape-0.01 ( -0.13%)
sun-fogPre-market 8.08$arrow-right-up0.10 (1.25%)
Market Closed (as of Feb 05, 21:00 EDT)
favorite-chart

Relative Strenght

67
favorite-chart

Volume Buzz

50%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

16%

Quote Panel

Shape
Updated February 6, 2025
1W -3.39 % 1M 1.40 % 3M -7.32 % 1Y 48.88 %

Key Metrics

Shape
  • Market Cap

    3.69B


  • Shares Outstanding

    461.96M


  • Share in Float

    141.52M


  • Dividende

    0


  • Earning Date

    07 Mar 2025


  • Price Target

    7.98


  • Average Volume

    1.19M


  • Beta

    1.175


  • Range

    5.01-9.475


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.amneal.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

AMRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape313%

2025-Revenue

$0.70

Shape1742%

2025-EPS

$427M

Shape191%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

11.00(37.84%)

Number of analyst

1

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+28%

0.23
vs 0.18

Q1.23

arrow
arrow

N/A

0.12
vs 0.12

Q2.23

arrow
arrow

N/A

0.19
vs 0.19

Q3.23

arrow
arrow

+36%

0.19
vs 0.14

Q4.23

arrow
arrow

-39%

0.14
vs 0.23

Q1.24

arrow
arrow

+17%

0.14
vs 0.12

Q2.24

arrow
arrow

-16%

0.16
vs 0.19

Q3.24

arrow
arrow

-16%

0.16
vs 0.19

Q4.24

arrow
arrow

+7%

0.15
vs 0.14

Q1.25

arrow
arrow

+7%

0.15
vs 0.14

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+14%

609.8M  vs 536.9M

Q1.23

arrow
arrow

+12%

557.5M  vs 497.6M

Q2.23

arrow
arrow

+7%

599M  vs 559.4M

Q3.23

arrow
arrow

+14%

620M  vs 545.6M

Q4.23

arrow
arrow

+1%

617M  vs 609.8M

Q1.24

arrow
arrow

+18%

659.2M  vs 557.5M

Q2.24

arrow
arrow

+17%

701.8M  vs 599M

Q3.24

arrow
arrow

+13%

702.5M  vs 620M

Q4.24

arrow
arrow

+15%

708.5M  vs 617M

Q1.25

arrow
arrow

+5%

690.5M  vs 659.2M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-3%

-0.03
vs -0.01

Q1.23

arrow
arrow

-7%

-0.07
vs -0.03

Q2.23

arrow
arrow

+8%

0.08
vs -0.07

Q3.23

arrow
arrow

+6%

0.06
vs 0.08

Q4.23

arrow
arrow

-499%

-4.99
vs 0.06

Q1.24

arrow
arrow

+144%

1.44
vs -4.99

Q2.24

arrow
arrow

-10%

-0.10
vs 1.44

Q3.24

arrow
arrow

+0%

0
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

158

158
vs 151

5%

Q1.23

arrow
arrow

146

146
vs 158

-8%

Q2.23

arrow
arrow

128

128
vs 146

-12%

Q3.23

arrow
arrow

144

144
vs 128

13%

Q4.23

arrow
arrow

153

153
vs 144

6%

Q1.24

arrow
arrow

179

179
vs 153

17%

Q2.24

arrow
arrow

184

184
vs 179

3%

Q3.24

arrow
arrow

185

185
vs 184

1%

Earnings Growth

Latest News